Lantheus Holdings, Inc. Inventory, Finished Goods, Net of Reserves
Lantheus Holdings, Inc. (LNTH) had Inventory, Finished Goods, Net of Reserves of $20.33 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-06
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $20.33M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $22.31M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $22.41M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $21.92M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $20.33M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $22.31M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $22.41M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $21.92M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $22.05M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $27.94M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $23.07M 10-K · filed 2026-02-26 |
| 2024-09-30 | $20.93M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $20.84M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $20.16M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $18.96M 10-K · filed 2025-02-26 |
| 2023-09-30 | $19.56M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $15.09M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $13.29M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $7.25M 10-K · filed 2024-02-22 |
| 2022-09-30 | $8.89M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $7.66M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $7.32M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $6.58M 10-K · filed 2023-02-23 |
| 2021-09-30 | $7.22M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.45M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $6.45M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $8.53M 10-K · filed 2022-02-24 |
| 2020-09-30 | $7.52M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.71M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $6.76M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $8.31M 10-K · filed 2021-02-25 |
| 2019-09-30 | $9.77M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $11.25M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $11.52M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $17.66M 10-K · filed 2020-02-25 |
| 2018-09-30 | $15.51M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $12.86M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $10.60M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $10.12M 10-K · filed 2019-02-20 |
| 2017-09-30 | $6.76M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $5.96M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $6.07M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $4.02M 10-K · filed 2018-02-26 |
| 2016-09-30 | $4.51M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $4.66M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $4.47M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $5.71M 10-K · filed 2017-02-23 |
| 2015-09-30 | $5.28M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $7.13M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $7.75M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |